欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0277/002
药品名称Abiloz 2mg/ 0.6mg/ 1.2mg orange lozenges
活性成分
    • amylmetacresol 0.6 mg
    • DICHLOROBENZYL ALCOHOL 1.2 mg
    • lidocaine hydrochloride 2.0 mg
剂型Lozenge
上市许可持有人Geiser Pharma S.L Camino Labiano 45B Multiva Alta, Navarra 31192 Spain
参考成员国 - 产品名称Malta (MT)
互认成员国 - 产品名称
    • Bulgaria (BG)
      Abiloz
    • Poland (PL)
    • Lithuania (LT)
      -
许可日期2019/11/14
最近更新日期2020/02/13
药物ATC编码
    • R02AA20 various
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase